BiotechTube
Home/Patrys/Brian Leedman
BL

Brian Leedman

Non‑Executive Director

Patrys

Therapeutic Areas

OncologyImmunologyNeurology

Patrys Pipeline

DrugIndicationPhase
RLS-2202Acute DeliriumPhase 1
PAT-DX1Vasculitis / Inflammatory DiseasePreclinical
PAT-DX3Vasculitis / Inflammatory DiseasePreclinical
Deoxymab Oncology CandidateSolid Tumor CancerPreclinical

Leadership Team at Patrys

PC
Peter Christie
Chairman
View full Patrys profile